SM-19712

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameSM-19712
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndothelin-converting enzyme 1 inhibitors
TargetsEndothelin-converting enzyme 1
Therapy Area/IndicationsReperfusion InjuryRenal Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDainippon Sumitomo Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDainippon Sumitomo Pharma Co Ltd
Active IndicationsN/A
Inactive IndicationsReperfusion InjuryRenal Insufficiency

Other Information

ATC CodeN/A
Related LinksN/A